US Nuclear Corp (OTC: UCLE) has announced its second quarter financial results, revealing a net loss reduction of over 54% compared to the same period last year. The company, which specializes in nuclear radiation detection and measurement, expects trading in its common stock to resume shortly. CEO Bob Goldstein highlighted that adjusting for non-cash charges and a delayed shipment, the first half net loss would have been approximately $301,000, a 49% reduction from the $617,404 loss in the first half of 2024. The company attributes this improvement to a new policy of rejecting low-margin or high-risk projects.
Goldstein stated, ''Although our 2nd quarter results were close to breakeven, we would have shown a small profit in the 2nd quarter if not for the delayed shipment. We are anticipating profit in the 3rd quarter, and for the full-year.'' The company's strategic moves include closing two transactions totaling $475,000 with equity partners in the nuclear-fusion sector. US Nuclear owned shares in MIFTI and MIFTEC, which merged on September 10, 2025, resulting in US Nuclear holding 1,022,710 MIFTI shares. Goldstein expressed excitement about the merger and the potential for long-term value, noting the company will continue to seek opportunities in fission and fusion reactor space.
Nikki Truax, Director of Operations at Overhoff Technology, US Nuclear's main manufacturing and sales operation, emphasized the need to expand the sales team. ''We are still combining the extensive product lines of Optron, the LA operation now consolidated with Overhoff Technologies in Milford, Ohio, as well as ECC, our calibration and service arm. Our combined product lines total over 250 distinct products, and we need to dramatically expand the number of skilled technical salespeople,'' Truax said. The company is actively seeking sales representatives, distributors, and an experienced VP of Sales to support its growing customer base.
For a link to our 2025 2nd quarter Q, please click this link.
